Labiotech.eu (blog) |
Broken Promises: Adocia Takes Eli Lilly to Court for Ditching its Diabetes Treatment
Labiotech.eu (blog) Adocia is unhappy with Eli Lilly, which walked away from their diabetes collaborations, which has left the biotech without a Phase III partner. Not long ago, they were working together to produce new diabetes treatments but now the relationship between … Adocia demands $200 million for Lilly's alleged diabetes deal breachesThe Pharma Letter Financial Newsletter – ZacksZacks Eli Lilly And Company – LLY – Stock Price Today – ZacksZacks SEC.gov all 46 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.